GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE Drug Patent Profile
✉ Email this page to a colleague
When do Guaifenesin And Dextromethorphan Hydrobromide patents expire, and when can generic versions of Guaifenesin And Dextromethorphan Hydrobromide launch?
Guaifenesin And Dextromethorphan Hydrobromide is a drug marketed by Actavis Labs Fl, Amneal Pharms, Aurobindo Pharma, Dr Reddys, Perrigo R And D, and Sun Pharm. and is included in six NDAs.
The generic ingredient in GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE is dextromethorphan hydrobromide; guaifenesin. There are twenty-three drug master file entries for this compound. Sixty-three suppliers are listed for this compound. Additional details are available on the dextromethorphan hydrobromide; guaifenesin profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE?
- What are the global sales for GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE?
- What is Average Wholesale Price for GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE?
Summary for GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE
US Patents: | 0 |
Applicants: | 6 |
NDAs: | 6 |
Finished Product Suppliers / Packagers: | 59 |
What excipients (inactive ingredients) are in GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE? | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE excipients list |
DailyMed Link: | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE at DailyMed |
Pharmacology for GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE
Drug Class | Expectorant Sigma-1 Agonist Uncompetitive N-methyl-D-aspartate Receptor Antagonist |
Mechanism of Action | Sigma-1 Receptor Agonists Uncompetitive NMDA Receptor Antagonists |
Physiological Effect | Decreased Respiratory Secretion Viscosity Increased Respiratory Secretions |